2. Lipids
  3. Isotope-Labeled Lipids
  4. Isotope-Labeled Fatty Esters

Isotope-Labeled Fatty Esters

 

Isotope-Labeled Fatty Esters (70):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-113147AS
    L-Palmitoylcarnitine-d3 hydrochloride 1334532-26-1 99.94%
    L-Palmitoylcarnitine-d3 hydrochloride is the deuterium labeled L-Palmitoylcarnitine hydrochloride. L-Palmitoylcarnitine hydrochloride, a long-chain acylcarnitine and a fatty acid metabolite, accumulates in the sarcolemma and deranges the membrane lipid environment during ischaemia. L-Palmitoylcarnitine hydrochloride inhibits KATP channel activity, without affecting the single channel conductance, through interaction with Kir6.2.
    L-Palmitoylcarnitine-d<sub>3</sub> hydrochloride
  • HY-W004290S
    Methyl heptadecanoate-d33 1219804-81-5 99.52%
    Methyl heptadecanoate-d33 is the deuterium labeled Methyl heptadecanoate (HY-W004290). Methyl heptadecanoate (C17:0 methyl ester) is the methyl ester derivative of heptadecanoic acid (HY-W004284). Methyl heptadecanoate is used as an internal standard for quantitative calibration of fatty acids in GC-MS analysis.
    Methyl heptadecanoate-d<sub>33</sub>
  • HY-114293S
    Acetyl coenzyme A-13C2 lithium
    Acetyl coenzyme A-13C2 lithium is the 13C-labeled Acetyl coenzyme A (HY-114293). Acetyl-coenzyme A (Acetyl-CoA) is a membrane-impermeant central metabolic intermediate, participates in the TCA cycle and oxidative phosphorylation metabolism. Acetyl-coenzyme A, regulates various cellular mechanisms by providing (sole donor) acetyl groups to target amino acid residues for post-translational acetylation reactions of proteins. Acetyl Coenzyme A is also a key precursor of lipid synthesis.
    Acetyl coenzyme A-<sup>13</sup>C<sub>2</sub> lithium
  • HY-114293S5
    Acetyl coenzyme A-d3 121443-44-5
    Acetyl coenzyme A-d3 (Acetyl-CoA-d3) is the deuterium labeled Acetyl coenzyme A (HY-114293). Acetyl-coenzyme A (Acetyl-CoA) is a membrane-impermeant central metabolic intermediate, participates in the TCA cycle and oxidative phosphorylation metabolism. Acetyl-coenzyme A, regulates various cellular mechanisms by providing (sole donor) acetyl groups to target amino acid residues for post-translational acetylation reactions of proteins. Acetyl Coenzyme A is also a key precursor of lipid synthesis.
    Acetyl coenzyme A-d<sub>3</sub>
  • HY-107855S
    DL-Mevalonolactone-d7 347840-19-1 99.27%
    DL-Mevalonolactone-d7 is the deuterium labeled DL-Mevalonolactone. DL-Mevalonolactone ((±)-Mevalonolactone) is the δ-lactone form of mevalonic acid, a precursor in the mevalonate pathway. DL-Mevalonolactone (Mevalonolactone) decreases mitochondrial membrane potential (?Ψm), NAD(P)H content and the capacity to retain Ca2+ in the brain, besides inducing mitochondrial swelling.
    DL-Mevalonolactone-d<sub>7</sub>
  • HY-N1446S6
    Oleic acid-d34 350671-54-4
    Oleic acid-d34 (9-cis-Octadecenoic acid-d34) is the deuterium labeled Oleic acid (HY-N1446). Oleic acid (9-cis-Octadecenoic acid) is an abundant monounsaturated fatty acid. Oleic acid is a Na+/K+ ATPase activator.
    Oleic acid-d<sub>34</sub>
  • HY-W718042
    1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 2692623-34-8
    1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 is a deuterated 3-monochloropropanediol (3-MCPD) glycidyl ester.
    1-Lauroyl-2-decanoyl-3-chloropropanediol-d<sub>5</sub>
  • HY-113161S1
    L-Octanoylcarnitine-d9 2847775-88-4
    L-Octanoylcarnitine-d9 is deuterium labeled L-Octanoylcarnitine. L-Octanoylcarnitine is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine can be used for the research of breast cancer.
    .
    L-Octanoylcarnitine-d<sub>9</sub>
  • HY-113261S
    Oleoylcarnitine-d9 2847775-85-1 99.0%
    Oleoylcarnitine-d9 is deuterium labeled Oleoylcarnitine. Oleoylcarnitine, the metabolite which accumulates through suppression of fatty acid β-oxidation, can enhance hepatocarcinogenesis via STAT3 activation.
    Oleoylcarnitine-d<sub>9</sub>
  • HY-W015305S
    Ethyl octanoate-d15 1219798-38-5 99.40%
    Ethyl octanoate-d15 is the deuterium labeled Ethyl octanoate.
    Ethyl octanoate-d<sub>15</sub>
  • HY-N2086S
    Ethyl palmitate-d31 1215721-57-5 98.0%
    Ethyl palmitate-d31 is the deuterium labeled Ethyl palmitate. Ethyl palmitate, a fatty acid ethyl ester (FAEE), shows a marked preference for the synthesis of ethyl palmitate and ethyl oleate over other FAEEs in human subjects after ethanol consumption. Ethyl palmitate is used as a hair- and skin-conditioning agent.
    Ethyl palmitate-d<sub>31</sub>
  • HY-B1934S1
    Methyl stearate-d35 29823-25-4 99.9%
    Methyl stearate-d35 is the deuterium labeled Methyl stearate (HY-B1934) . Methyl stearate, isolated from Rheum palmatum L. is a compopent of of soybean and rapeseed biodiesels.
    Methyl stearate-d<sub>35</sub>
  • HY-139951S
    3-Hydroxy-3-methylglutaryl-Coenzyme A-d3 ammonium
    3-Hydroxy-3-methylglutaryl-Coenzyme A-d3 (ammonium) is the deuterium labeled 3-Hydroxy-3-methylglutaryl-Coenzyme A ammonium.
    3-Hydroxy-3-methylglutaryl-Coenzyme A-d<sub>3</sub> ammonium
  • HY-W004288S
    Methyl tetradecanoate-d27 434349-93-6 99.0%
    Methyl tetradecanoate-d27 is the deuterium labeled Methyl myristate. Methyl myristate is a saturated fatty acid methyl ester obtained from the esterification of myristic acid. Methyl myristate shows a high melanin induction in B16F10 melanoma.
    Methyl tetradecanoate-d<sub>27</sub>
  • HY-W770410
    9-PAHSA-13C4 2748638-71-1 99.9%
    9-PAHSA-13C4 is 13C-labeled 9-PAHSA. 9-PAHSAis an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSAsignificantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSAinduces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSAregulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSAdoes not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSAcan be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease.
    9-PAHSA-<sup>13</sup>C<sub>4</sub>
  • HY-N1482S1
    Methyl palmitate-d31 29848-79-1 99.11%
    Methyl palmitate-d31 is the deuterium labeled Methyl palmitate. Methyl palmitate, an acaricidal compound occurring in green walnut husks, inhibits phagocytic activity and immune response. Methyl palmitate also posseses anti-inflammatory and antifibrotic effects.
    Methyl palmitate-d<sub>31</sub>
  • HY-144026S
    9-PAHSA-d9 1809222-43-2
    9-PAHSA-d9 is the deuterium labeled 9-PAHSA (HY-120657). 9-PAHSA is an orally active endogenous GPR120 agonist (EC50=18 μM). 9-PAHSA significantly inhibits LPS-induced inflammatory responses by blocking the NF-κB pathway. 9-PAHSA induces adipocyte browning, enhances glucose uptake and reduces lipid accumulation, while improving mitochondrial function and the survival rate of steatotic hepatocytes. In terms of neuroprotection, 9-PAHSA regulates the expression of REST and BDNF in the prefrontal cortex of diabetic mice, and effectively prevents spatial working memory deficits and abnormal social behaviors. 9-PAHSA does not directly regulate insulin secretion or improve systemic insulin sensitivity, and possesses specific anti-inflammatory, metabolic regulatory and neuroprotective properties. 9-PAHSA can be used in the research of diabetes-related cognitive impairment, obesity and non-alcoholic fatty liver disease.
    9-PAHSA-d<sub>9</sub>
  • HY-N1482S
    Methyl palmitate-13C16 99.80%
    Methyl palmitate-13C16 is the 13C labeled Methyl palmitate. Methyl palmitate, an acaricidal compound occurring in green walnut husks, inhibits phagocytic activity and immune response. Methyl palmitate also posseses anti-inflammatory and antifibrotic effects.
    Methyl palmitate-<sup>13</sup>C<sub>16</sub>
  • HY-W775262S
    Δ9-Tetrahydrocannabinolic acid-d3 1548417-60-2
    Δ9-Tetrahydrocannabinolic acid-d3 is the deuterium labeled Δ9-Tetrahydrocannabinolic acid. Δ9-Tetrahydrocannabinolic acid is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.
    Δ9-Tetrahydrocannabinolic acid-d<sub>3</sub>
  • HY-W749785
    rac-1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 2692623-32-6
    rac-1-Lauroyl-2-decanoyl-3-chloropropanediol-d5 is a deuterated 3-monochloropropanediol (3-MCPD) glycidyl ester.
    rac-1-Lauroyl-2-decanoyl-3-chloropropanediol-d<sub>5</sub>